Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood

In the field of blood sciences, nanotechnology could offer new routes to address challenging and pressing issues facing rare blood diseases and disorders. In the case of biopharmaceutical products from human blood origin, nanofiltration can permit the effective removal of a wide range of viruses (more than four to six logs of enveloped/non-enveloped viruses), with the absence of a denaturing effect on plasma proteins. In addition, nanomaterials can be used as artificial cell-like systems (compartmentalized biomimetic nanocontainers), which are especially used in drug delivery. In this regard, cell-like nanorobots can swim through blood and remove harmful bacteria. For artificial blood, the nanotechnological approach can fabricate artificial red blood cells, platelet substitutes, and white blood cell substitutes with their inherent enzyme and other supportive systems. In addition, nanomaterials can promote blood vessel growth and reserve red blood cells at a positive temperature. Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood outlines the fundamental design concepts and emerging applications of nanotechnology in hematology, blood transfusion, and artificial blood. It is an important reference source for materials scientists, engineers and biomedical scientists who are looking to increase their understanding of how nanotechnology can lead to more efficient blood treatments.  Provides information to the reader about how nanotechnology can be used to create more efficient solutions for blood transfusions and hematology treatmentsExplores the major nanomaterial types that are used for these treatmentsAssesses the major challenges of using nanomaterials hematology